» Articles » PMID: 31890660

Effect of Selenium Supplementation on Glycemic Indices: a Meta-analysis of Randomized Controlled Trials

Overview
Specialty Endocrinology
Date 2020 Jan 1
PMID 31890660
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The association between selenium supplementation and glycemic indices seems to be a controversial issue. This systematic review and meta-analysis was conducted to evaluate the effect of selenium supplementation on glycemic indices.

Methods: We systematically searched PubMed/MEDLINE, ISI/WOS, and Scopus (from their commencements up to Jan 2016) for relevant studies examining the association between intake of selenium and glycemic indices. The data were extracted from relevant qualified studies and estimated using the random-effect or pooled model and standardized mean difference (SMD) with 95% confidence interval (CI).

Results: Twelve articles published between 2004 and 2016 were included. In all the studies, the participants were randomly assigned to an intervention group ( = 757) or a control group( = 684). All the studies were double blind, placebo controlled trials. Selenium supplementation resulted in a significant decrease in homeostasis model of assessment-estimated β-cell function (HOMA-B) (SMD: -0.63; 95%CI: -0.89 to -0.38) and a significant increase in quantitative insulin sensitivity check index (QUICKI) (SMD: by 0.74; 95%CI: 0.49 to 0.1) as compared with the controls. There were no statistically significant improvements in glycemic indices, such as fasting plasma glucose (FPG), insulin, homeostasis model of assessment-estimated insulin resistance (HOMA-IR), Hemoglobin A1c (HbA1c) and adiponectin.

Conclusion: This meta-analysis indicated that selenium supplementation significantly decreased HOMA-B and increased QUICKI score. There was no statistically significant improvement in FPG, insulin, HOMA-IR, HbA1c and adiponectin indices following selenium supplementation.

Citing Articles

Differential association of selenium exposure with insulin resistance and β-cell function in middle age and older adults.

Rodriguez-Hernandez Z, Bel-Aguilar J, Moreno-Franco B, Grau-Perez M, Redon J, Gomez-Ariza J Nutr Diabetes. 2025; 15(1):5.

PMID: 39948355 PMC: 11825691. DOI: 10.1038/s41387-025-00361-2.


Serum Selenium Levels and Their Relationship with Insulin Resistance in Individuals with Polycystic Ovary Syndrome.

Karami M, Almaghrabi S, Banasr O, Hussein K Biol Trace Elem Res. 2024; .

PMID: 39500832 DOI: 10.1007/s12011-024-04435-7.


Selenium Species in Diabetes Mellitus Type 2.

Pyrzynska K, Sentkowska A Biol Trace Elem Res. 2023; 202(7):2993-3004.

PMID: 37880477 PMC: 11074226. DOI: 10.1007/s12011-023-03900-z.


Selenium intake and multiple health-related outcomes: an umbrella review of meta-analyses.

Wang P, Chen B, Huang Y, Li J, Cao D, Chen Z Front Nutr. 2023; 10:1263853.

PMID: 37781125 PMC: 10534049. DOI: 10.3389/fnut.2023.1263853.


Effects of Selenium Supplementation on the Indices of Disease Activity, Inflammation and Oxidative Stress in Patients with Rheumatoid Arthritis: a Randomized Clinical Trial.

Zamani B, Taghvaee F, Akbari H, Mohtashamian A, Sharifi N Biol Trace Elem Res. 2023; 202(4):1457-1467.

PMID: 37477848 DOI: 10.1007/s12011-023-03782-1.


References
1.
Jamilian M, Razavi M, Fakhrie Kashan Z, Ghandi Y, Bagherian T, Asemi Z . Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol (Oxf). 2014; 82(6):885-91. DOI: 10.1111/cen.12699. View

2.
Nikuei P, Davoodian N, Tahamtan I, Keshtkar A . Predictive value of miR-210 as a novel biomarker for pre-eclampsia: a systematic review protocol. BMJ Open. 2016; 6(9):e011920. PMC: 5051509. DOI: 10.1136/bmjopen-2016-011920. View

3.
DIPLOCK A . Antioxidants and disease prevention. Mol Aspects Med. 1994; 15(4):293-376. DOI: 10.1016/0098-2997(94)90005-1. View

4.
Mao J, Bath S, Vanderlelie J, Perkins A, Redman C, Rayman M . No effect of modest selenium supplementation on insulin resistance in UK pregnant women, as assessed by plasma adiponectin concentration. Br J Nutr. 2015; 115(1):32-8. DOI: 10.1017/S0007114515004067. View

5.
Wang C, Yang S, Zhang N, Mu Y, Ren H, Wang Y . Long-term supranutritional supplementation with selenate decreases hyperglycemia and promotes fatty liver degeneration by inducing hyperinsulinemia in diabetic db/db mice. PLoS One. 2014; 9(7):e101315. PMC: 4077766. DOI: 10.1371/journal.pone.0101315. View